Health care; Diabetes solutions; Human vaccines; Innovative drugs; CHC; Emerging markets; Animal health and Genzyme
Sanofi, a global and integrated health care leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of health care with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer health care, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
In the early 1980s, Sanofi opened its first office in China. Sanofi’s China headquarters in Shanghai are supported by 11 regional offices. As of 2013, Sanofi had 8,500 employees in more than 1300 cities and counties in China.
Sanofi is engaged in integrated R&D in China, from drug target identification to late-stage clinical studies. Its China and Asia Pacific R&D Center is located in Shanghai.
Sanofi China has a diversified business that ranges from pharmaceuticals, vaccines, consumer health care and rare diseases (Genzyme) to animal health (Merial).
Sanofi has seven manufacturing facilities in China to meet the increasing demand of the China market. These plants are located in Beijing, Hangzhou (two plants), Shenzhen, Tangshan, Nanchang and Nanjing.